San Francisco, CA, United States of America

Alexandre Antoine Rochat

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Adherium (Nz) Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandre Antoine Rochat. Retrieved from https://idiyas.com/inventor/alexandre-antoine-rochat-oeo96sfx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Alexandre Antoine Rochat

Introduction

Alexandre Antoine Rochat is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of inhalation devices, holding two patents that enhance the effectiveness of medication delivery systems. His work is particularly relevant in the context of respiratory health.

Latest Patents

Rochat's latest patents include a compliance monitor for dry powder inhalers and a compliance monitor for metered dose inhalers. These innovations aim to improve patient adherence to prescribed inhalation therapies, ultimately leading to better health outcomes.

Career Highlights

Rochat is currently employed at Adherium Limited, a company focused on improving medication adherence through innovative technology. His role at Adherium allows him to leverage his expertise in developing advanced inhalation devices.

Collaborations

Rochat has collaborated with talented individuals such as Yoshikazu Hoshino and Gadi Amit, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Alexandre Antoine Rochat's contributions to inhalation technology through his patents and work at Adherium Limited highlight his commitment to improving respiratory health. His innovations are paving the way for more effective treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…